Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Aug 13, 2024 11:47am
75 Views
Post# 36176634

RE:RE:Goodbye Johnny

RE:RE:Goodbye Johnnywrong info.?? Mr Rigby was CEO of Revolo Biotherapeutics.

I think it is ONCY who are do braindead to update the details for their own board of directors... direct quote from ONCY webpage... "He is currently the Group Chief Executive Officer (CEO) of Revolo Biotherapeutics, where he leads a team focused on the development of therapies for autoimmune and allergic diseases. "

Yet, he left them in Feb 2024, so ONCY's information on their own website is half a year out of date..It doesn't surprise me, as nobody who works there seems to make progress on anything.

Black Holes... hmmm...  well since I first started selling my position in ONCY late last October, this has dropped over 50%... and still falling... You fellas eat yer hearts out...  company must be worth billions, it's obvious to the entire investing community... hence the crazy high stock price...

ah well.. some folk just won't be told...




<< Previous
Bullboard Posts
Next >>